Skip to main content
SciePro - stock.adobe.com
01:0

Helmholtz Diabetes Center

Our research at the Helmholtz Diabetes Center aims at understanding the molecular bases underlying all forms of diabetes, its heterogeneity and risk factors, including obesity as well as its complications and comorbidities. We combine world-leading basic research with clinical intervention and cohort studies to develop tomorrow’s diabetes precision medicine.

Our research at the Helmholtz Diabetes Center aims at understanding the molecular bases underlying all forms of diabetes, its heterogeneity and risk factors, including obesity as well as its complications and comorbidities. We combine world-leading basic research with clinical intervention- and cohort studies to develop tomorrow’s diabetes precision medicine. 

Our Research Areas

Kateryna_Kon - stock.adobe.com

Diabetes, Autoimmunity, Obesity, and Other Risk Factors

We identify risk factors for diabetes in children and adults and its complications. Our world-class basic research enables us to define new biomarker for its development and progression and therapeutic targets.

Helmholtz Munich | Andreas Pfohl

Prevention and Personalized Therapies

We are leading in early detection and prevention of type 1 and type 2 diabetes as well as development of innovative personalized therapies to combat diabetes and obesity.

Regenerative Therapies for Diabetes and its Complications

We develop new venues for cell-based therapies, to reestablish a health metabolic function. We jointly work to identify the molecular basis of diabetes complications and means for their remission.

Our Scientists at the Helmholtz Diabetes Center

Prof. Dr. Stephan Herzig

Director & Head of Division Diabetic Complications View profile

Prof. Dr. Heiko Lickert

Institute Director and Group Leader Insulin/IGF signalling in metabolism and growth & Islet Biology View profile

Univ.-Prof. Dr. med. Anette-Gabriele Ziegler

Institute Director, Chair of Diabetes and Gestational Diabetes, Klinikum rechts der Isar and Technical University of Munich, Director of the Global Platform for the Prevention of Autoimmune Diabetes (GPPAD) View profile

Prof. Dr. Matthias Blüher

HI-MAG Director and Head of Clinical Obesity Research Group View profile
Martin Hrabě De Angelis

Prof. Dr. Dr. h.c. Martin Hrabě De Angelis

Research Director Helmholtz Munich, Full Professor and Chair of Experimental Genetics Technical University Munich, Director of the Institute of Experimental Genetics Helmholtz Munich View profile

Prof. Dr. Nina Henriette Uhlenhaut

Institute Director View profile

Prof. Dr. Andreas Birkenfeld

Head of Insitute, Medical doctor View profile

Upcoming Events

24.06.2022

Diabetes Conference - Latest Therapies in Diabetes

The 9th Helmholtz Diabetes Conference will take place on September 26-28 at Künstlerhaus Munich on the topic 'Latest Therapies in Diabetes'. Internationally leading scientists in diabetes research are joining us to present and discuss their most recent data and achievements.

Selected Publications

See all

Networks and Affiliations

Contact Director of Operations

Dr. Tobias Schafmeier

Director of Operations

Contact Coordinator

Dr. Anne Caniard

Coordinator HDC

Building 3620, Room 315b